Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
This report elaborates on the current development of the Anti-Obesity Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
VIVUS
Zafgen, Inc
Pfizer, Inc
Novo Nordisk
Sanofi
Norgine BV
Alvogen (Lotus)
Eisai Co, Ltd
Orexigen Therapeutics, Inc
Merck & Co
Boehringer Ingelheim GmbH
AstraZeneca
Takeda Pharmaceutical Co, Ltd
By Type:
Peripherally Acting Drugs
Centrally Acting Drugs
By Application:
Prescription Drugs
OTC Drugs
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Anti-Obesity Drugs Market Overview 2018-2029
-
1.1 China Anti-Obesity Drugs Industry Development Overview
-
1.2 China Anti-Obesity Drugs Industry Development History
-
1.3 China Anti-Obesity Drugs Industry Market Size (2018-2029)
-
1.4 China Anti-Obesity Drugs Market Analysis by Type from Production Side
-
1.4.1 China Anti-Obesity Drugs Production Volume, Production Value and Growth Rate of Peripherally Acting Drugs (2018-2029)
-
1.4.2 China Anti-Obesity Drugs Production Volume, Production Value and Growth Rate of Centrally Acting Drugs (2018-2029)
-
1.5 China Anti-Obesity Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Anti-Obesity Drugs Sales Volume, Sales Value and Growth Rate of Prescription Drugs (2018-2029)
-
1.5.2 China Anti-Obesity Drugs Sales Volume, Sales Value and Growth Rate of OTC Drugs (2018-2029)
-
1.6 China Anti-Obesity Drugs Market Analysis by Region
-
1.6.1 North China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Anti-Obesity Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Anti-Obesity Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Anti-Obesity Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Anti-Obesity Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Anti-Obesity Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Anti-Obesity Drugs Industry Development
Chapter 3 Anti-Obesity DrugsIndustry Chain Analysis
-
3.1 Anti-Obesity Drugs Industry Chain
-
3.2 Anti-Obesity Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Anti-Obesity Drugs Market
-
3.3 Anti-Obesity Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Anti-Obesity Drugs Market
Chapter 4 China Anti-Obesity Drugs Market, by Type
-
4.1 China Anti-Obesity Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Anti-Obesity Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Anti-Obesity Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Anti-Obesity Drugs Production Volume and Growth Rate of Peripherally Acting Drugs
-
4.5.2 China Anti-Obesity Drugs Production Volume and Growth Rate of Centrally Acting Drugs
Chapter 5 China Anti-Obesity Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Anti-Obesity Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Anti-Obesity Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Anti-Obesity Drugs Market Size and Growth Rate of Prescription Drugs
-
5.5.2 China Anti-Obesity Drugs Market Size and Growth Rate of OTC Drugs
Chapter 6 China Anti-Obesity Drugs Market, by Region
-
6.1 China Anti-Obesity Drugs Production Volume and Production Value, by Region
-
6.2 China Anti-Obesity Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Anti-Obesity Drugs Market Analysis
-
7.1 North China Anti-Obesity Drugs Market, by Type
-
7.2 North China Anti-Obesity Drugs Market, by Application
Chapter 8 Central China Anti-Obesity Drugs Market Analysis
-
8.1 Central China Anti-Obesity Drugs Market, by Type
-
8.2 Central China Anti-Obesity Drugs Market, by Application
Chapter 9 South China Anti-Obesity Drugs Market Analysis
-
9.1 South China Anti-Obesity Drugs Market, by Type
-
9.2 South China Anti-Obesity Drugs Market, by Application
Chapter 10 East China Anti-Obesity Drugs Market Analysis
-
10.1 East China Anti-Obesity Drugs Market, by Type
-
10.2 East China Anti-Obesity Drugs Market, by Application
Chapter 11 Northeast China Anti-Obesity Drugs Market Analysis
-
11.1 Northeast China Anti-Obesity Drugs Market, by Type
-
11.2 Northeast China Anti-Obesity Drugs Market, by Application
Chapter 12 Southwest China Anti-Obesity Drugs Market Analysis
-
12.1 Southwest China Anti-Obesity Drugs Market, by Type
-
12.2 Southwest China Anti-Obesity Drugs Market, by Application
Chapter 13 Northwest China Anti-Obesity Drugs Market Analysis
-
13.1 Northwest China Anti-Obesity Drugs Market, by Type
-
13.2 Northwest China Anti-Obesity Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 VIVUS
-
14.1.1 VIVUS Company Profile
-
14.1.2 VIVUS Anti-Obesity Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Zafgen, Inc
-
14.2.1 Zafgen, Inc Company Profile
-
14.2.2 Zafgen, Inc Anti-Obesity Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer, Inc
-
14.3.1 Pfizer, Inc Company Profile
-
14.3.2 Pfizer, Inc Anti-Obesity Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Novo Nordisk
-
14.4.1 Novo Nordisk Company Profile
-
14.4.2 Novo Nordisk Anti-Obesity Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sanofi
-
14.5.1 Sanofi Company Profile
-
14.5.2 Sanofi Anti-Obesity Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Norgine BV
-
14.6.1 Norgine BV Company Profile
-
14.6.2 Norgine BV Anti-Obesity Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Alvogen (Lotus)
-
14.7.1 Alvogen (Lotus) Company Profile
-
14.7.2 Alvogen (Lotus) Anti-Obesity Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Eisai Co, Ltd
-
14.8.1 Eisai Co, Ltd Company Profile
-
14.8.2 Eisai Co, Ltd Anti-Obesity Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Orexigen Therapeutics, Inc
-
14.9.1 Orexigen Therapeutics, Inc Company Profile
-
14.9.2 Orexigen Therapeutics, Inc Anti-Obesity Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Merck & Co
-
14.10.1 Merck & Co Company Profile
-
14.10.2 Merck & Co Anti-Obesity Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Boehringer Ingelheim GmbH
-
14.11.1 Boehringer Ingelheim GmbH Company Profile
-
14.11.2 Boehringer Ingelheim GmbH Anti-Obesity Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 AstraZeneca
-
14.12.1 AstraZeneca Company Profile
-
14.12.2 AstraZeneca Anti-Obesity Drugs Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Takeda Pharmaceutical Co, Ltd
-
14.13.1 Takeda Pharmaceutical Co, Ltd Company Profile
-
14.13.2 Takeda Pharmaceutical Co, Ltd Anti-Obesity Drugs Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Anti-Obesity Drugs Industry Research Conclusions
-
15.2 Anti-Obesity Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Anti-Obesity Drugs Industry Market Size (2018-2029)
-
Figure China Anti-Obesity Drugs Production Volume, Production Value and Growth Rate of Peripherally Acting Drugs (2018-2029)
-
Figure China Anti-Obesity Drugs Production Volume, Production Value and Growth Rate of Centrally Acting Drugs (2018-2029)
-
Figure China Anti-Obesity Drugs Sales Volume, Sales Value and Growth Rate of Prescription Drugs (2018-2029)
-
Figure China Anti-Obesity Drugs Sales Volume, Sales Value and Growth Rate of OTC Drugs (2018-2029)
-
Figure North China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Anti-Obesity Drugs Market Size and Growth Rate from 2018-2029
-
Figure Anti-Obesity Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Anti-Obesity Drugs Market Share by Type in 2018
-
Figure China Anti-Obesity Drugs Market Share by Type in 2023
-
Figure China Anti-Obesity Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Anti-Obesity Drugs Production Volume and Growth Rate of Peripherally Acting Drugs (2018-2023)
-
Figure China Anti-Obesity Drugs Production Volume and Growth Rate of Centrally Acting Drugs (2018-2023)
-
Figure China Anti-Obesity Drugs Market Share by Application in 2018
-
Figure China Anti-Obesity Drugs Market Share by Application in 2023
-
Figure China Anti-Obesity Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Anti-Obesity Drugs Market Size and Growth Rate of Prescription Drugs (2018-2023)
-
Figure China Anti-Obesity Drugs Market Size and Growth Rate of OTC Drugs (2018-2023)
-
Table China Anti-Obesity Drugs Production Volume by Region (2018-2023)
-
Table China Anti-Obesity Drugs Production Volume Share by Region (2018-2023)
-
Figure China Anti-Obesity Drugs Production Volume Share by Region (2018-2023)
-
Table China Anti-Obesity Drugs Production Value by Region (2018-2023)
-
Table China Anti-Obesity Drugs Production Value Share by Region (2018-2023)
-
Figure China Anti-Obesity Drugs Production Value Share by Region (2018-2023)
-
Table China Anti-Obesity Drugs Sales Volume by Region (2018-2023)
-
Table China Anti-Obesity Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Anti-Obesity Drugs Sales Volume Share by Region (2018-2023)
-
Table China Anti-Obesity Drugs Sales Value by Region (2018-2023)
-
Table China Anti-Obesity Drugs Sales Value Share by Region (2018-2023)
-
Figure China Anti-Obesity Drugs Sales Value Share by Region (2018-2023)
-
Table North China Anti-Obesity Drugs Production Volume by Type (2018-2023)
-
Table North China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Table North China Anti-Obesity Drugs Sales Volume by Application (2018-2023)
-
Table North China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Anti-Obesity Drugs Production Volume by Type (2018-2023)
-
Table Central China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Anti-Obesity Drugs Sales Volume by Application (2018-2023)
-
Table Central China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Anti-Obesity Drugs Production Volume by Type (2018-2023)
-
Table South China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Table South China Anti-Obesity Drugs Sales Volume by Application (2018-2023)
-
Table South China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Anti-Obesity Drugs Production Volume by Type (2018-2023)
-
Table East China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Table East China Anti-Obesity Drugs Sales Volume by Application (2018-2023)
-
Table East China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Anti-Obesity Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Anti-Obesity Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Anti-Obesity Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Anti-Obesity Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Anti-Obesity Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Anti-Obesity Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Anti-Obesity Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Anti-Obesity Drugs Sales Volume Share by Application (2018-2023)
-
Table VIVUS Company Profile
-
Table VIVUS Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Zafgen, Inc Company Profile
-
Table Zafgen, Inc Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer, Inc Company Profile
-
Table Pfizer, Inc Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Novo Nordisk Company Profile
-
Table Novo Nordisk Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Norgine BV Company Profile
-
Table Norgine BV Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Alvogen (Lotus) Company Profile
-
Table Alvogen (Lotus) Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Eisai Co, Ltd Company Profile
-
Table Eisai Co, Ltd Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Orexigen Therapeutics, Inc Company Profile
-
Table Orexigen Therapeutics, Inc Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck & Co Company Profile
-
Table Merck & Co Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim GmbH Company Profile
-
Table Boehringer Ingelheim GmbH Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceutical Co, Ltd Company Profile
-
Table Takeda Pharmaceutical Co, Ltd Anti-Obesity Drugs Revenue, Price and Gross (2018-2023)
-
